Permanent Injunction Issued Against Dietary Supplements Containing Undisclosed Drugs
date:Sep 08, 2018
serious health risks to patients who have underlying medical conditions such as high blood pressure and heart disease. Sildenafil is a phosphodiesterase type-5 (PDE-5) inhibitor. The products are drugs as defined by the FDC Act because they are intended to prevent, treat, or cure disease conditions and/or affect the structure or function of the body.

Donald D. Ashley, director of the Office of Compliance in the FDAs Center for Drug Evaluation and Research said in a statement, Despite our warnin
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/19 00:23